Dr. Bravo is a co-investigator in a study of the safety and efficacy of Dysport in the treatment of migraine headaches. She has made presentations on topics such as emerging therapies for the management of migraine. Her work has appeared in Current Pain and Headache Reports, Neurology, and other publications. Her special interests within neurology include health disparities, as well as DEI research.